Briviact (brivaracetam) is a prescription medication that belongs to a class of drugs known as antiepileptic or anticonvulsant medications. It is specifically designed to treat partial-onset seizures in patients with epilepsy, a neurological disorder characterized by recurrent, unprovoked seizures. Briviact works by modifying the activity of neurotransmitters in the brain, thereby reducing the frequency and intensity of seizures. It can be prescribed for adults and children aged 4 years and older, and is available in several forms, including tablets, oral solution, and injectable solution, allowing for flexibility in administration based on patient needs and preferences. Like all medications, Briviact may have side effects, and its use should be closely monitored by a healthcare professional. When using Briviact, a medication commonly prescribed for epilepsy, it's crucial to adhere strictly to your doctor's instructions and thoroughly read the label that accompanies the medicine. This ensures you're aware of the correct dosage and any potential interactions with other medications you might be taking. Inform your doctor about all other medicines you're currently using to avoid adverse reactions. Side effects of Briviact can range from common ones like drowsiness, dizziness, and fatigue, to more rare but serious effects such as mood changes or suicidal thoughts. Due to its potential to cause drowsiness and dizziness, it's important to be cautious about driving or operating heavy machinery until you know how Briviact affects you. Always prioritize safety and consult your healthcare provider with any concerns regarding Briviact or its side effects.
Your cart contains products from a separate order category. Adding this product will remove those items from your cart.
Important Supply & Pricing Update about GLP-1 Medications
Due to manufacturer-driven price increases from Eli Lilly and other suppliers, prices for GLP-1 medications including Mounjaro have risen significantly. Global supply constraints may also result in slightly longer lead times.
We remain committed to securing the best possible pricing and supply for our customers and will continue to provide updates as the situationĀ evolves.